G-nib 250 mg Tablet

G-Nib 250 mg Tablet contains gefitinib, an oral targeted anticancer medicine. It is mainly used for eligible patients with non-small cell lung cancer. Gefitinib works by blocking EGFR tyrosine kinase signaling that supports cancer-cell growth.

BUY NOW

G-Nib 250 mg Tablet is an EGFR tyrosine kinase inhibitor used for non-small cell lung cancer in patients with appropriate tumor characteristics. Gefitinib blocks abnormal EGFR signaling, which can help slow the growth and spread of cancer cells. The tablet is taken orally according to the oncologist’s prescribed treatment schedule. Treatment requires medical supervision and monitoring for response and possible adverse effects.

Technical Specification

Specification Details
Active Ingredient Gefitinib
Strength 250 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets
Manufacturer BDR Pharmaceuticals Internationals Pvt Ltd

Product Also Known As

G-Nib 250 mg Tablet, Gefitinib 250 mg Tablet, G-Nib Gefitinib Tablet, Gefitinib Lung Cancer Tablet, EGFR Inhibitor Tablet, Targeted Lung Cancer Treatment Tablet